Literature DB >> 20383183

Bladder cancer: nomogram aids clinical decision making after radical cystectomy.

Shahrokh F Shariat, Derya Tilki.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20383183     DOI： 10.1038/nrurol.2010.42

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.

Authors:  Pierre I Karakiewicz; Shahrokh F Shariat; Ganesh S Palapattu; Amiel E Gilad; Yair Lotan; Craig G Rogers; Amnon Vazina; Amit Gupta; Patrick J Bastian; Paul Perrotte; Arthur I Sagalowsky; Mark Schoenberg; Seth P Lerner
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

2.  Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.

Authors:  Jose A Karam; Yair Lotan; Pierre I Karakiewicz; Raheela Ashfaq; Arthur I Sagalowsky; Claus G Roehrborn; Shahrokh F Shariat
Journal:  Lancet Oncol       Date:  2007-02       Impact factor: 41.316

3.  Nomograms provide improved accuracy for predicting survival after radical cystectomy.

Authors:  Shahrokh F Shariat; Pierre I Karakiewicz; Ganesh S Palapattu; Gilad E Amiel; Yair Lotan; Craig G Rogers; Amnon Vazina; Patrick J Bastian; Amit Gupta; Arthur I Sagalowsky; Mark Schoenberg; Seth P Lerner
Journal:  Clin Cancer Res       Date:  2006-11-15       Impact factor: 12.531

4.  Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.

Authors:  Bernard H Bochner; Michael W Kattan; Kinjal C Vora
Journal:  J Clin Oncol       Date:  2006-07-24       Impact factor: 44.544

5.  Multi-institutional validation of the predictive value of Ki-67 labeling index in patients with urinary bladder cancer.

Authors:  Vitaly Margulis; Yair Lotan; Pierre I Karakiewicz; Yves Fradet; Raheela Ashfaq; Umberto Capitanio; Francesco Montorsi; Patrick J Bastian; Matthew E Nielsen; Stefan C Müller; Jérôme Rigaud; Lukas C Heukamp; George Netto; Seth P Lerner; Arthur I Sagalowsky; Shahrokh F Shariat
Journal:  J Natl Cancer Inst       Date:  2009-01-13       Impact factor: 13.506

Review 6.  Nomograms for bladder cancer.

Authors:  Shahrokh F Shariat; Vitaly Margulis; Yair Lotan; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2008-01-15       Impact factor: 20.096

Review 7.  An updated catalog of prostate cancer predictive tools.

Authors:  Shahrokh F Shariat; Pierre I Karakiewicz; Claus G Roehrborn; Michael W Kattan
Journal:  Cancer       Date:  2008-12-01       Impact factor: 6.860

8.  Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy.

Authors:  Shahrokh F Shariat; Pierre I Karakiewicz; Raheela Ashfaq; Seth P Lerner; Ganesh S Palapattu; Richard J Cote; Arthur I Sagalowsky; Yair Lotan
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

9.  Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.

Authors:  Andrew J Vickers; Angel M Cronin; Michael W Kattan; Mithat Gonen; Peter T Scardino; Matthew I Milowsky; Guido Dalbagni; Bernard H Bochner
Journal:  Cancer       Date:  2009-12-01       Impact factor: 6.860

10.  Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers.

Authors:  Andrew J Vickers; Angel M Cronin; Elena B Elkin; Mithat Gonen
Journal:  BMC Med Inform Decis Mak       Date:  2008-11-26       Impact factor: 2.796
  10 in total
  3 in total

Review 1.  Biomolecular predictors of urothelial cancer behavior and treatment outcomes.

Authors:  Michael Rink; Eugene K Cha; David Green; Jens Hansen; Brian D Robinson; Yair Lotan; Arthur I Sagalowsky; Felix K Chun; Pierre I Karakiewicz; Margit Fisch; Douglas S Scherr; Shahrokh F Shariat
Journal:  Curr Urol Rep       Date:  2012-04       Impact factor: 3.092

2.  UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.

Authors:  Teppei Morikawa; Taketo Kawai; Hiroyuki Abe; Haruki Kume; Yukio Homma; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

Review 3.  Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets.

Authors:  Nico C Grossmann; Victor M Schuettfort; Benjamin Pradere; Marco Moschini; Fahad Quhal; Hadi Mostafaei; Francesco Soria; Satoshi Katayama; Ekaterina Laukhtina; Keiichiro Mori; Reza Sari Motlagh; Cédric Poyet; Mohammad Abufaraj; Pierre I Karakiewicz; Shahrokh F Shariat; David D'Andrea
Journal:  Onco Targets Ther       Date:  2021-01-13       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.